Agile Therapeutics, Inc.

Q1 2021 13F Holders

Symbol
AGRX
CUSIP
00847L100
Type
Equity
Class
COM
Num filings
85
Total reported value, excl. options
$113 M
Manager Report Date Value ($000) Shares Option Type